A pioneer in targeted radiotherapy – Marika Nestor featured in Onkologi i Sverige

What drives a cancer researcher to start a biotech company? In a newly published feature in Onkologi i Sverige, our CEO and co-founder, Professor Marika Nestor, shares insights from her journey through academia, innovation, and translational cancer research.

The article traces her early steps into science, the growth of her all-female research group in Uppsala, and her longstanding focus on developing targeted radiopharmaceutical therapies for difficult-to-treat cancers. It also touches on the founding of Akiram Therapeutics as a way to bring research closer to clinical application and patient benefit.

Read the full article (in Swedish) on Onkologi i Sverige:
Nestorn i strålterapi: på en strålande väg mot nya cancerläkemedel